D J Stewart1, W K Evans. Show Affiliations » 1. Ontario Cancer Treatment and Research Foundation, Ottawa Regional Cancer Centre, Canada.
Abstract
Mesh: See more » AdultAmphotericin B/administration & dosageAnimalsAntimetabolites/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useButhionine SulfoximineCalcium Channel Blockers/administration & dosageCalmodulin/antagonists & inhibitorsCardiotonic Agents/administration & dosageChildClinical Trials as TopicDipyridamole/administration & dosageDrug EvaluationDrug ResistanceDrug SynergismDrug Therapy, CombinationFemaleHumansKetoconazole/administration & dosageMaleMethionine Sulfoximine/administration & dosageMethionine Sulfoximine/analogs & derivativesMiceNeoplasms/drug therapyNitroimidazoles/administration & dosageXanthines/administration & dosage
Substances: See more » AntimetabolitesAntineoplastic AgentsCalcium Channel BlockersCalmodulinCardiotonic AgentsNitroimidazolesXanthinesMethionine SulfoximinemethylxanthineButhionine SulfoximineDipyridamoleAmphotericin BKetoconazole
Year: 1989 PMID: 2659168 DOI: 10.1016/0305-7372(89)90002-9
Source DB: PubMed Journal: Cancer Treat Rev ISSN: 0305-7372 Impact factor: 12.111